State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer

European Medical Journal Oncology

Elena Castro¹  David Olmos¹  Nuria Romero¹ 

[1] Prostate Cancer and Genitourinary Tumours Unit, Clinical Research Programme, Spanish National Cancer Research Centre, Madrid, Spain. Prostate cancer unit, Clara Campal Comprehensive Cancer Center, HM Universitario Sanchinarro, Madrid, Spain;

关键词: Bladder Cancer;    Renal Cancer;    testicular cancer;    treatment options;   

DOI  :  

来源: DOAJ

【 摘 要 】

Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the understanding of castration-resistant PrCa which has led to the development of new drugs that have an impact on patient survival. This review summarises the recent advances in the management of the disease.

【 授权许可】

Unknown